marketing-medtech

**Founder:** Rakia Jaziri (Gammoudi) — Présidente (founder & CEO), Wealthy Technology; Associate Professor in AI/NLP/Generative AI, Université Paris 8 (Laboratoire Paragraphe)
**Background:** tech | verified: True — Tech / AI. Rakia Jaziri (Gammoudi) is Associate Professor in AI at Université Paris 8 (Laboratoire Paragraphe / LIASD), specializing in machine learning, NLP, and generative AI, and is Présidente (founder/CEO) of Wealthy Technology, a Paris-based SAS (founded 29 Feb 2024, SIREN 985133008) building generative AI for healthcare/regulatory writing and drug development. Her background is squarely technical.
**Stage / fundraise:** Pre-seed / very early stage. SAS incorporated 29 Feb 2024 (~16 months old as of June 2026), 15k€ capital, registered at ParisSanté Campus (75015 Paris), at least 1 employee, no financial statements filed yet. / No equity round identified. Non-dilutive momentum: i-Lab 2025 laureate (France 2030 / Bpifrance national innovation contest) for the AUTOREGMED project. Pappers flags equity capital below half of share capital — a cash/early-burn signal consistent with pre-seed timing and a likely upcoming raise.
**Regulatory trigger:** Product automates regulatory writing across drug development (pharma/biotech regulatory documents). Domain is heavily regulated (EMA/ANSM dossiers, AMM). As GenAI used in a healthcare/regulated context, the product itself may face SaMD/AI-Act/quality-system expectations; either way the team must build with auditable, traceable, documented software — exactly OmDev's compliance-evidence wheelhouse (requirements-to-code-to-test traceability, SOUP register).
**Email:** rakia.jaziri@univ-paris8.fr (confidence medium) — Google Scholar lists a verified email at univ-paris8.fr for Rakia Jaziri; standard Paris 8 staff pattern is prenom.nom@univ-paris8.fr. This is her academic address (reachable, but not the company address). No company/Wealthy Technology email is published — checked the website (no contact details exposed) and registry pages; not fabricating a wealthy-technology.com address.
**LinkedIn:** https://fr.linkedin.com/in/rakia-jaziri-phd-93214b25 **Website:** https://wealthy-technology.com/
**Score:** 12 -> Tier A
**Hook:** You're scaling AUTOREGMED right after the i-Lab 2025 win — turning regulatory-writing GenAI into a product while still holding a Paris 8 chair, with no CTO surfaced and a lean team. OmDev gives you an instant senior dev squad plus a dedicated CTO at a fixed monthly price ~3x cheaper than hiring in-house, and because your domain is regulated drug documentation, our build pipeline produces compliance evidence as you go (signed SOUP register, requirements-to-code-to-test traceability) so your software file is audit-ready — letting you spend i-Lab money on product, not on recruiting a team you don't yet have time to manage.

---

## Founder & background
Rakia Jaziri (registry name GAMMOUDI Rakia, née Jaziri) is founder & Présidente of Wealthy Technology and an Associate Professor in AI/NLP/Generative AI at Université Paris 8 (Laboratoire Paragraphe), h-index ~10 ([Scholar](https://scholar.google.com/citations?user=fbI5g1oAAAAJ&hl=en); [Paris 8](https://laboratoire-paragraphe.univ-paris8.fr/-rakia-jaziri-)).
She is a deep-tech / academic founder — strong on AI research, no finance, insurance, pharma-exec or clinician background found.
In role since 04/03/2024, she appears as the sole registered dirigeant ([Pappers](https://www.pappers.fr/entreprise/wealthy-technology-985133008)).
**Why OmDev fits:** a brilliant AI researcher without a CTO or build team is exactly who benefits from a turnkey senior dev squad + dedicated CTO.

## Funding & momentum
Wealthy Technology is a SAS incorporated 29 Feb 2024, 15k€ capital, based at ParisSanté Campus, 75015 Paris ([Pappers](https://www.pappers.fr/entreprise/wealthy-technology-985133008)).
i-Lab 2025 laureate (France 2030 / Bpifrance national innovation contest) for the AUTOREGMED project ([data.gouv](https://www.data.gouv.fr/datasets/laureats-i-lab-concours-national-daide-a-la-creation-dentreprises-de-technologies-innovantes); [gouv.fr](https://www.enseignementsup-recherche.gouv.fr/fr/france-2030-147-laureats-recompenses-lors-de-la-ceremonie-20242025-des-concours-d-innovation-de-l-100154)).
No equity round identified; Pappers flags equity below half of share capital — consistent with pre-seed timing and an upcoming raise.
**Why OmDev fits:** fixed-price, ~3x-cheaper-than-in-house delivery lets fresh i-Lab grant money go to product, not headcount.

## Product & regulatory
Product = GenAI automating regulatory writing across the drug-development lifecycle (AUTOREGMED); declared activity is "création et développement d'outils et de solutions dans le domaine de la santé", NAF 62.01Z ([Pappers](https://www.pappers.fr/entreprise/wealthy-technology-985133008)).
Domain is heavily regulated (EMA/ANSM dossiers, AMM submissions); GenAI in a regulated health context demands auditable, traceable, documented software.
**Why OmDev fits:** the build pipeline emits compliance evidence as it ships — signed SOUP register per build + requirements-to-code-to-test traceability feeding the IEC 62304/MDR-style file (OmDev does not certify).

## Pain & buying signals
Single registered dirigeant, no CTO surfaced; founder splits time with a full Paris 8 professorship; one-person/very-small SAS implies a thin engineering team ([Pappers](https://www.pappers.fr/entreprise/wealthy-technology-985133008)).
Equity-below-half-of-capital alert signals cash pressure; the i-Lab grant adds milestone/delivery pressure to ship a credible product.
Best reachable contact is her verified academic email; no company email published, no team page on the site ([site](https://wealthy-technology.com/)).
**Why OmDev fits:** instant senior team + dedicated CTO at a fixed monthly price removes the recruiting bottleneck a solo academic founder can't afford to fight right now.

---
**Sources:** https://www.pappers.fr/entreprise/wealthy-technology-985133008 · https://www.data.gouv.fr/datasets/laureats-i-lab-concours-national-daide-a-la-creation-dentreprises-de-technologies-innovantes · https://www.enseignementsup-recherche.gouv.fr/fr/france-2030-147-laureats-recompenses-lors-de-la-ceremonie-20242025-des-concours-d-innovation-de-l-100154 · https://scholar.google.com/citations?user=fbI5g1oAAAAJ&hl=en · https://laboratoire-paragraphe.univ-paris8.fr/-rakia-jaziri- · https://fr.linkedin.com/in/rakia-jaziri-phd-93214b25 · https://www.societe.com/societe/wealthy-technology-985133008.html · https://infonet.fr/dirigeants/66aa60b35da7ac2c4b30c5bb/ · https://wealthy-technology.com/